Prof. Dr. Anja Katrin Boßerhoff

Lehrstuhl für Biochemie und Molekulare Medizin

Role of melanoma inhibitory activity in melanocyte senescence (2019) Feuerer L, Lamm S, Henz I, Kappelmann-Fenzl M, Haferkamp S, Meierjohann S, Hellerbrand C, et al. Journal article Bone Morphogenetic Protein-6 Inhibits Fibrogenesis in Scleroderma Offering Treatment Options for Fibrotic Skin Disease (2019) Arndt S, Karrer S, Hellerbrand C, Boßerhoff AK Journal article Detection of Human Tumor Markers with THz Metamaterials (2018) Weisenstein C, Schaar D, Schmeck M, Wigger AK, Boßerhoff AK, Bolivar PH Conference contribution Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering. (2018) Rottensteiner-Brandl U, Detsch R, Sarker B, Lingens L, Köhn K, Kneser U, Boßerhoff AK, et al. Journal article Importance of the RNA Binding Protein Hu-antigen R in malignant Melanoma (2018) Liebig J, Boßerhoff AK Conference contribution Extracellular Acidosis leads to the Development of a senescent-like Phenotype and molecular Reprogramming of human Melanoma Cells (2018) Böhme I, Boßerhoff AK Conference contribution CYLD - A potential Mediator of tissue-specific Melanoma Metastasis (2018) Schott M, de Jel MM, Boßerhoff AK, Kuphal S Conference contribution SiRNA-Knockdown einer neuen Argonaute2 Spleißvariante verringert die tumorigenen Eigenschaften von Melanomzellen. (2018) Linck L, Boßerhoff AK Conference contribution, Abstract of a poster RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas (2018) Kunz M, Loeffler-Wirth H, Dannemann M, Willscher E, Doose G, Kelso J, Kottek T, et al. Journal article MicroRNA-sequencing data analyzing melanoma development and progression (2018) Linck L, Liebig J, Voeller D, Eichner N, Lehmann G, Meister G, Boßerhoff AK Journal article